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60TH ANNIVERSARY OF AJHG
The Editors’ Recollections
on the Occasion of the 60th Anniversary
of The American Journal of Human Genetics
Volume 1, Number 1 of The American Journal of Human Geneticswas published in September 1949. The ﬁrst paper was an 18-page preface
to the journal by H. J. Muller, president of The American Society of Human Genetics, entitled ‘‘Progress and Prospects in Human
Genetics.’’ CharlesW. Cotterman served as the ﬁrst editor, and since that time a dozen other human geneticists have shared that distinc-
tion. In recognition of the 60th anniversary of AJHG, recollections of ﬁve editors are recorded here.Arno G. Motulsky: 1970–1975
When I became the editor for the January 1970 issue, taking
over from H. Eldon Sutton, our journal had already been
published for 22 years. The masthead of The American Jour-
nal of Human Genetics indicated that genetics articles from
four different areas—medicine, anthropology, psychology,
and social sciences—were invited, but few articles from
the behavioral and social sciences were submitted.
Editorial policy was not to publish single-case reports.
For papers on new statistical methods, we encouraged
authors to provide speciﬁc applications to real data. Occa-
sional annotations were welcomed. Our rejection rate of
scientiﬁc articles was around 50%.
Eleven of 359 articles published during my six years as
editor received more than 50 citations. Six of these papers
dealt with statistical methodology, two with population
differences, and three with clinical genetics and genetic
counseling.
Even though research in medical and human genetics
represents only a small proportion of all biomedical
research, there were 12 journals of human and medical
genetics in September 1970, including two journals with
social and eugenic content—a large number for a small
ﬁeld.
Jim Neel, celebrating the 25th anniversary of The Amer-
ican Society of Human Genetics, using the number of
papers presented at the 1974 ASHG meeting, as an indi-
cator of research favored by ASHG members, pointed out
that these papers represented only 1–2% of the total
content of human and medical genetics. A similar assess-
ment now—35 years later—would be interesting. Does
current research cover a larger proportion of our ﬁeld?
I elaborated onmy views of human andmedical genetics
in the 1971 William Allan Memorial Award Lecture.1
Among a variety of topics discussed, I expressed the belief
that control of common, complex diseases by genetics
would not be achievable by 1996. This prediction was
expressed while our research team, with future Nobel
laureate Joseph Goldstein as a postdoctoral fellow, was
working on the genetics of coronary heart disease in theDOI 10.1016/j.ajhg.2009.08.008. ª2009 by The American Society of Human
The Americanhyperlipidemias. In another area, my assessment of the
ethical problems raised by the then current and future
approaches to prevention, treatment, and research in
genetic diseases was published in Science2 and covered
genetic disorders, including birth defects, intrauterine
diagnosis, abortion, artiﬁcial insemination, and in vitro
fertilization.
Jerome Lejeune, in his 1969 Allen Award address,
expressed his deeply felt rejection of abortion in a discus-
sion of Down syndrome and other chromosomal aberra-
tions in the 1970 publication.3 His presentation was long
remembered by the audience, most of whom probably
did not share his views on abortion.
David E. Comings: 1979–1986
At the 1977 San Diego meeting of The American Society of
Human Genetics, Arno Motulsky cornered me at the door
and asked whether I would consider taking over as editor of
The American Journal of Human Genetics. Bill Mellman was
having health problems and wanted to pass the responsi-
bilities on to a new editor. After recovering from the shock,
I agreed to the great honor of editing this esteemed journal.
Ever since its inception,AJHG featured on the front cover
the name ‘‘The American Journal of Human Genetics’’ in
black text on a white cloud. This was sometimes referred
to as the ‘‘chicklets’’ cover. The chewing gum had to go. I
felt my ﬁrst task was to give our journal a sexier, more
modern cover.We combined three ﬁgures—the DNA helix,
a family pedigree, and p2 þ 2pq þ q2—to illustrate its
breadth of coverage from molecular biology to clinical
and population genetics. I note that it has since become
a ritual for almost every subsequent editor to announce
his or her arrival with a redesigned cover.
It is easy for me to remember one of the greatest high-
lights of my tenure of 1979 to 1986. With the advent of
high-throughput DNA sequencing, revolutionary events
now seem standard fare for the ﬁeld of human genetics,
but in the late 1970s, the previous decades had seenmostly
the explosive effect of chromosome banding. This advance
was tapering off by the time I took over the helm, andGenetics. All rights reserved.
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despite the increased resolution that banding provided,
the ﬁeld was still struggling with working out how to iden-
tify the chromosomal location of individual human genes.
Drosophila genetics, with its giant chromosome bands, was
still leaving human genetics wallowing in the comparative
doldrums. I still remember my personal excitement when I
received a call from David Botstein, urging rapid handling
of a paper that he and his colleagues were submitting,
entitled ‘‘Construction of a genetic linkage map in man
using restriction fragment length polymorphisms.’’4 For
those readers interested in the history of our ﬁeld, I repro-
duce the following abstract of this paper:
We describe a new basis for the construction of
a genetic linkage map of the human genome. The
basic principle of the mapping scheme is to develop,
by recombinant DNA techniques, random single-
copyDNA probes capable of detecting DNA sequence
polymorphisms, when hybridized to restriction
digests of an individual’s DNA. Each of these probes
will deﬁne a locus. Loci can be expanded or con-
tracted to include more or less polymorphism by
further application of recombinant DNA technology.
Suitably polymorphic loci can be tested for linkage
relationships in human pedigrees by established
methods; and loci canbearranged into linkagegroups
to forma truegeneticmapof ‘‘DNAmarker loci.’’ Pedi-
grees in which inherited traits are known to be segre-
gating can then be analyzed, making possible the
mapping of the gene(s) responsible for the trait with
respect to the DNA marker loci, without requiring
direct access to a speciﬁed gene’s DNA. For inherited
diseases mapped in this way, linked DNA marker
loci can be used predictively for genetic counseling.
I immediately sent the paper for review, urging a quick
return. Tomy astonishment, one of the esteemed reviewers
recommended rejection. I passed this on to the authors,
usingmyeditorial prerogative to let themknow that despite
this curmudgeon’s opinion, their paper was still accepted.
They could add theirs to the long list of groundbreaking
ideas, papers, or grants that were initially confronted with
critical reviews. For me, the paper was sufﬁciently exciting
to stimulate me to wax poetically in an editorial, calling it
‘‘the birth of the age of ‘the new genetics,’’’ and so it was.
Mapping the Huntington disease gene was one of the ﬁrst
of many successes with this new technique.
Those of my generation remember the refrain ‘‘Old
soldiers never die, they just fade away.’’ I end this with
a personal note of where this old editor has faded. After
37 years of work, I retired from the City of Hope Medical
Center in 2002. One of the ﬁrst books that I read in my
leisure time claimed that mutation rates were too low for
evolution to occur, along with other Intelligent Design
nonsense. I knew from our own research with microsatel-
lite polymorphisms that themutation rates in some impor-
tant gene regulatory segments of DNA could be very rapid.
This stimulated me to write a series of rebuttals. Once I322 The American Journal of Human Genetics 85, 321–327, Septemstarted, it was hard to stop, and two years and 694 pages
later, this resulted in a book, entitled Did Man Create
God?—a review of the interaction of genetics, evolution,
brain science, and religion. This was followed bymy taking
up golf (a sport I had long thought was a waste of time),
traveling, bird photography, and, ﬁve years after becoming
a widower, marriage. Fading into retirement can be totally
wonderful. And to quote another famous man, but relative
to grant writing, ‘‘Free at last, free at last.’’
Charles J. Epstein: 1987–1993
‘‘Seven Momentous Years.’’ That was the title of the edito-
rial that I wrote in December 1993, in the last issue of The
American Journal of Human Genetics that I edited.5 They
were indeed momentous years, and, as I phrased it then,
‘‘much has happened—to the journal, to human genetics
as a science, to medical genetics as a profession, and to
me personally.’’ Rather than my trying to summarize it
all here, I invite the reader to take a few minutes to read
the editorial.
When I assumed editorship of AJHG in 1988, I immedi-
ately decided that if the journal was to take its place among
the major publications covering human genetics, it would
have to look the part. Therefore, it was reconﬁgured with
a larger page size, new typography, and a glossy cover
that was mostly black to show off a new depiction of the
molecular structure of DNA. But this was merely a matter
of cosmetics; the more important decision to be made
was what AJHG should be. There was no question that its
primary goal, as it has always been, was to publish high-
quality research in human genetics. However, perceptions
at that time, and even now, about what constituted the
‘‘best’’ journals in which to publish work in the molecular
biology area dictated that AJHG would rarely receive what
would be considered the must cutting-edge and paradigm-
shifting articles. By contrast, when it came to statistical
and population genetics and related areas, AJHG was the
place to publish, and all of the tenmost cited AJHG articles,
each with over a thousand citations, fall into this category.
Highest on the list is the article published by the late
Richard Spielman and his colleagues, during my editor-
ship, on the transmission test for linkage disequilibrium.6
At the time that I became the editor, The American Journal
of Human Genetics, as the journal of the world’s leading
human genetics research organization, was, and still is,
unique among all of the journals publishing in the area
of human genetics. As such, I believed that it had broader
responsibilities beyond publishing outstanding scientiﬁc
research articles. Therefore, in addition to the traditional
book reviews, the Allan Award and Presidential addresses,
and the occasional obituary, there could be found newly
added invited editorials commenting on articles of partic-
ular interest, opinions, reviews, a Human Genetics Educa-
tion section (complete with its own mortar board logo),
statements and committee reports from The Americanber 11, 2009
Society of Human Genetics, and even a 30-year history of
the Bar Harbor Short Course in Human Genetics, complete
with over 100 of Victor McKusick’s inimitable snapshots of
many of us when we were much younger. There were also
articles that could not be strictly considered as scientiﬁc
research per se—perhaps the most noted of these being
the one by Billings et al.7 on genetic discrimination (no.
201 on the list of most cited AJHG articles).
With all of this newly broadened content, the Letters to
the Editor section became much more lively. The most
spirited exchange of letters came after publication of Eric
Lander’s invited editorial on the forensic applications of
DNA typing.8 ‘‘Spirited’’ is perhaps too mild a word, since
the intensity of the letters from a variety of prosecutors
and geneticists necessitated the writing of a ‘‘real’’ edito-
rial9 in response to the accusation that the peer-reviewed
journal had, in one correspondent’s opinion, permitted
the publication of an invited editorial that was ﬂawed
and potentially injurious. While this contretemps may
seem quaint in retrospect, it was deadly (no pun intended)
serious back in 1991 when major efforts were being made
to use DNA typing for forensic purposes. In one other
editorial worthy of note—there were only ﬁve in all—I
used the ‘‘bully pulpit’’ that editors have to advocate for
the then-proposed splitting of genetic counselors from
the American Board of Medical Genetics so that the board
might be admitted to the American Board of Medical
Specialties as a recognized medical specialty.10 This edito-
rial marked a very traumatic time in the history of orga-
nized medical genetics, one from which the profession
has fortunately recovered.
At this time, when we are celebrating the 200th anniver-
sary of the birth of Charles Darwin and are thinking a lot
about evolution, it is worth recognizing that sciences and
organizations, like living organisms, evolve, and human
and medical genetics are no exceptions. Human genetics
didn’t crawl out of the primordial ooze until the nine-
teenth century and medical genetics until considerably
later, and their early progress was slow. However, the evolu-
tion of both accelerated greatly after the middle of the 20th
century—sometimes with incremental changes, some-
times with saltatory jumps. The American Journal of Human
Genetics, which started in 1949, has borne witness to virtu-
ally the entire course of this accelerating evolution, and
each of its editors has had the opportunity to monitor its
progress. In my case, it was the wide-scale introduction
of molecular genetics and recombinant DNA technology
into human genetics research, just after the invention of
PCR, and the maturation of the professional institutions
of medical genetics that were in the spotlight. What
a wonderful time to have been editor!
Peter H. Byers: 1993–1999
After being chosen to succeed Charlie Epstein as editor of
The American Journal of Human Genetics (I would be theThe Americanfourth editor with University of Washington ties), I visited
the University of Chicago Press (UCP) Journals Division
ofﬁce, apparently the ﬁrst such visit by an editor in their
recent memory. The choice of editor had been made at
the March 1993 ASHG spring board meeting, I had found
a managing editor, Roberta Wilkes, who would stay for
my full tenure as editor, and by early June, we were
prepared to begin accepting new manuscripts in July.
When I walked into the press ofﬁce, the then-head of the
Journals Division, Bob Shirrel, asked me whether I had
heard the news about Charlie and showed me a page of
The New York Times, bearing Charlie’s picture after the
attack by the Unabomber. So, rather than the leisurely
beginning that we had anticipated, with a slow ramp-up
to full speed, all of the editorial responsibilities for AJHG
shifted immediately from San Francisco to Seattle. Shelley
Diamond, Charlie’s managing editor, joined us for about
six weeks, primarily to handle revised manuscripts
from the preceding weeks. Controlled chaos presided for
about two months, as we made a very rapid transition
to what soon became a relatively smooth and growing
operation.
I had three major objectives when I applied for the posi-
tion of editor: to bring AJHG into the electronic age, to
speed manuscript processing, and to introduce a series of
review and assessment papers that highlighted new
advances and also commented on current papers. I discov-
ered that the UCP had published The Astrophysical Journal
as both a paper and an online effort for the previous couple
of years, and they were eager to extend this practice to their
portfolio of biological and medical journals. It took
a couple of years, but with the hard work of Evan Owens
and his informatics group, we made the transition to an
electronic journal with the then-unique feature (I think)
of rapid electronic publication of both HTML and PDF
versions prior to the assembly of the paper journal, now
almost universally followed. I think that this process
revived interest in publishing in AJHG; our submissions
grew from just under 400 to almost 1200 per year by
1999, my last year as editor.
Although this innovation sped manuscript publication,
it did little for the hands-on, labor-intensive process of
handling the paper that we inherited. It was only toward
the end of my tenure that we started the process of elec-
tronic submission that was then rapidly implemented by
Steve Warren.
Commentary was largely lacking from AJHG, with the
exception of the rare editorial and occasional letter to the
editor prompted by a scientiﬁc disagreement. We started
a monthly summary of papers that we thought interesting
in each issue, a task that fell to our ﬁrst editorial assistant,
who would later become our associate editor, John Ashke-
nas. John had the rare ability to succinctly summarize the
key points of a paper, place it into context, and suggest
new directions, all in the space of a couple hundred words.
He extended his innovation to commissioning a set of
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would be interesting to the human genetics community
and to ﬁnding people to comment on papers in each
edition. John was devoted to this task and worked very
well with authors, gently reminding them of deadlines,
providing references, and in some cases writing so much
of the commentaries that he was invited to join the list
of authors.
The process of going from typed submission to published
paper was more complex than I had imagined, and we ulti-
mately hired Patty Baskin to direct the technical processes.
She, too, stayed with AJHG until it moved to Atlanta.
At the beginning of my editorship, papers appeared in
the printed issue largely in the order in which they had
been accepted for publication. Although this might have
increased the chance that a reader would encounter, and
perhaps even glance through or read, a paper far from his
or her center of interest, it seemed ungainly to me. So we
ordered the papers by what seemed an impeccable logic,
starting with those that dealt with human genetics at the
nucleotide level and ending with those that dealt with it
at the population level, followed by more theoretical
papers or methods papers. I am not sure that anyone
outside of our ofﬁce realized that this was a conscious deci-
sion, but for me it gave structure to the journal contents
and organized the diversity of the ﬁeld.
I had thought that this strategy might put the more
inﬂuential papers near the top of the table of contents.
However, it is clear from review of highly cited papers pub-
lished during the period of 1994 to 1999 that nothing
could be further from the truth. It was the ‘‘back of the
bus’’ papers from the methods and population sections
that received the most interest, consistent with the recog-
nized principle that successful methods papers are usually
highly cited. In addition, this result reﬂected the rapidly
emerging interest in common disorders and the drive to
ﬁnd efﬁcient methods for detecting the underlying genetic
contributions. This process bloomed later on, but many of
the methodologic strategies that underlay it were pub-
lished in AJHG during that period.
I saw every submission as it came through the door, read
every abstract, and read the introduction and discussion of
most papers before deciding whether to return a paper
immediately or send it out for review. We reviewed about
half of the submissions and published just under a quarter.
Parsing this task reveals annual numbers of about 1000 ﬁrst
readings, 500 rejections without review, 500 readings of
external reviews, 200 postreview rejections, 300 revisions,
50 papers sent out for a second review, 50 subsequently
rejected, and about 250 published. At a minimum, I
reviewed each acceptedmanuscript three times. This trans-
lates into roughly 10–12 decisions per day during the 200 or
so working days at The Journal each year. Such a process
draws heavily on the experience and interest of a sole
editor, so each edition ofAJHG perforce reﬂects that editor’s
views. We had relatively few vituperative responses to our
decisions, but one paper that I rejected was published in
Nature Genetics, perhaps a beneﬁt to both journals.324 The American Journal of Human Genetics 85, 321–327, SeptemAlthough AJHG recently moved from the UCP to Cell
Press, my experience with the group at the UCP was enor-
mously rewarding. Bob Sherril, Everett Conner, Evan
Owens, and Jim Searle (the single sharp-eyed, Chicago style
devotee of a copyeditor who was ours alone) welcomed my
visits, taught me about the publication business and
process, visited us in Seattle, and started the tradition of
attending ASHG board meetings. They were committed to
the success of AJHG and managed the electronic transition
to bring us to the forefront of electronic publishing.
When I assumed the job, my closest association with
statistical and population genetics was that I could spell
the words. Indeed, word was around the community that
AJHG would devolve into a clinical journal in no time.
My frequent consultant during the ﬁrst three years, and
periodically thereafter, was Lynn Jorde, soon-to-be presi-
dent-elect of ASHG. I asked Lynn to extend his tenure on
the editorial board by three years, and once a month or
more, I would send him a paper, read it, try to explain to
him what I thought it meant, listen to his assessment,
and then, together with him, come to a decision about
publication. Lynn had the ability to make me think I could
understand these papers and move me over the rough
spots when they inevitably appeared. Reading parts of all
the papers, physically blue pencilling a number of them,
and discussing them with Lynn made this a period of
intense learning, during which I distilled my under-
standing of human and medical genetics. Difﬁcult some-
times but always rewarding, it gave me a deeper sense of
what we as human and medical geneticists do and of the
important questions that we ask.
The focus of human and medical genetics evolved
during the six years that I was editor of our journal, and I
think that with the help of our staff, our editorial board,
and our reviewers, we helped to both shape and reﬂect
those changes.
Stephen T. Warren: 1999–2005
The period that I was editor was an exciting time for
human genetics, with major changes in methodologies
and approaches, marked by the declared completion of
the human genome sequence. The genome sequence put
the ﬁeld into a fast-forwardmode and resulted in a windfall
of gene discoveries. This period also saw the dawn of the
era of microarrays, and the resulting genome scale data
were both exciting from a scientiﬁc standpoint and a
challenge from an editorial standpoint. How would we as
journals manage the massive data sets generated by micro-
arrays? The American Journal of Human Genetics had to
adjust its policies regarding access to full data sets. We
were one of the ﬁrst journals to make frequent use of
supplemental data and had to work with our publisher,
unfamiliar with this aspect of publishing, to develop
procedures to house the data and make it available to
readers.ber 11, 2009
The genome era also changed the way that we look for
genes. When we took over AJHG, highly penetrant loci
inﬂuencing disease phenotypes were largely found by
linkage analysis. For example, in the January 2000 issue,
we published nine papers on linkage, including one
single-family report. However, this approach was quickly
becoming overtaken by association studies with a focus
on complex disease. This was somewhat uncharted terri-
tory in terms of evaluation of signiﬁcance and led to
several heated discussions at editorial board meetings.
Although the standards were dynamic, we strived to lead
the ﬁeld in terms of requiring correction for multiple
testing (commonplace now, but not then) and replication.
But it was a learning experience. In hindsight, some of
papers that we published then would not even come close
to the standards of today—for example, papers of associa-
tion studies with fewer than 100 cases or controls.
Not only were there scientiﬁc revolutions during my
tenure as editor, but scientiﬁc publishing saw some major
changes as well. One that generated very heated debates
was the ‘‘open access’’ movement. Although not philo-
sophically opposed to the concept, I strongly disagreed
with the initial demands. For example, early on it was
proposed that all papers be published without peer review
and that readers should be allowed to post comments
online as sort of a post hoc peer review. While this may
work in some ﬁelds, in medically relevant areas I viewed
this as potentially dangerous, allowing the pseudoscience
views of charlatans to be legitimatized by publishing
under our banner. I’ve seen too many instances of megavi-
tamins being sold as cures for Down syndrome to believe
that such a policy would work. The other aspect of open
access that was poorly understood by its proponents was
the actual cost of running the editorial process. The initial
estimates wildly under estimated the cost. While we ran
a tight ship at The Journal, our costs would not be covered
by charges being discussed. Indeed, the online journals
that emerged from this movement, although highly
successful from a scientiﬁc viewpoint, still require subsi-
dizing grants and gifts to maintain operations. Regardless
of these operational disagreements, the concept of open
access was something I embraced. I believe that our
society can be proud of the fact that in 2002, AJHG was
among the very ﬁrst journals to release its contents freely
after six months of the publication date. Seven years later,
we still remain ahead of the curve; for example, the
current NIH policy requires open access 12 months after
publication.
Duringmy tenure as editor, we also ﬁnished up themove
to fully electronic submissions and reviews, initiated by
Peter Byers. This was quite a change—no more faxes and
FedExing of envelopes. Thinking back, this move by The
Journal, saving reams of paper, certainly made it a green
journal in more ways than one!
Overall, my time as editor was driven by our quest to
improve the ‘‘cutting edge’’ nature of AJHG. While AJHG
has had a long history of publishing very high-qualityThe Americanpapers, it sometimes took quite some time to eventually
publish a paper. Publication time became somewhat the
coin of the realm among journals publishing the latest
and greatest. While electronic publishing certainly made
substantial improvement, we also initiated a rapid review
track for exceptionally timely papers, often turning around
reviews in 24 hours or less. Word got out that AJHG could
now compete with any journal in terms of rapid publica-
tion time, and we enjoyed a marked increase in the
number of ‘‘gene discoveries.’’ When we took over AJHG
in 1999, only an occasional paper reporting the discovery
of a gene associated with a disease found its way into The
Journal, but by 2005, each issue usually had at least two
such papers. Besides this area, we also tried to be strong
stewards of what many saw as the ‘‘bread and butter’’ of
The Journal, statistical and population genetics. One of
the biggest personal surprises of being editor was my awak-
ened interest in these areas; obviously not as a practitioner
but as a reader. All of these changes paid off with annual
increases in AJHG’s impact factor, rising over two and
half full points during my tenure.
The ﬁnal accomplishment of my time as editor is the
introduction of the Cotterman Award in 2000 to highlight
the best paper to be published over the past year in AJHG
with a student or trainee member as ﬁrst author. I am
happy that this tradition has continued under my
successor as a small way to foster the careers of our youn-
gest members.
People often ask me whether I am glad that I rotated off
being editor and are surprised to learn that, in general, I
miss it. It was a singular educational experience for me,
and I would highly recommend it. It was an honor and
a privilege to be your editor and an experience that I shall
forever value.
Cynthia C. Morton: 2006–
The path tomy tenure as editor began during a coffee break
at a board of directors’ meeting of ASHG, held in Honolulu
in 2004. Peter Byers and Steve Warren encouraged me to
apply for the post, and I was simultaneously enormously
ﬂattered and frightened at the prospect. That meeting
was ﬁve years ago now. I remain ﬂattered, and the fright
has dissipated. I have deep gratitude to both of them for
sending me on this journey, and to The Society for
entrusting me with the care of this precious written record
of our ﬁeld. Without a doubt, being the editor of The
American Journal of Human Genetics will always be one of
the highlights of my career as a human geneticist.
I was very fortunate to have Robin Williamson join me
in the ofﬁce as the deputy editor, and then to add Kathryn
Bungartz as science editor. One of the ﬁrst tasks that Robin
and I took on was to give The Journal a facelift with a new
cover. We endeavored to use the cover as a teachable
moment in human genetics, beginning with Mendel’s
peas, and returned the background color to a shade ofJournal of Human Genetics 85, 321–327, September 11, 2009 325
green. Cover illustrations have included images represent-
ing color blindness, Hardy-Weinberg equilibrium, copy
number variants, and inherited breast cancer, and we
invite suggestions and contributions to provide monthly
genetics brain teasers. Some new features have been added,
including a series of articles titled Perspectives, edited by
a former AJHG editor, Arno Motulsky, and short summa-
ries of papers of interest to human geneticists, titled This
Month in Genetics, edited by a former AJHG deputy
editor, Kate Garber. Most recently, Kate has expanded
the summaries to include papers from Genetics
and Genetics in Medicine, representing a paper swap
with our sister societies, in a section titled This Month
in Our Sister Journals. In a further outreach effort to
our colleagues, beyond those in our sister societies repre-
sented by the paper swap (Genetics Society of America
and The American College of Medical Genetics), in
2008 I sought the board of directors’ approval to open
up the editorial board to human geneticists residing
outside of North America. Recognizing the global origin
of the submitted and published manuscripts, and the
wonderfully global nature of the scientiﬁc community,
the number of associate editors was increased by three.
This addition of associate editors, each serving terms of
three years, represented the ﬁrst increase since 1970,
under Arno Motulsky’s editorship. As with the new cover,
it was time for a change!
No doubt the biggest change that we undertook was
a publisher competition that resulted in a transition in
January 2008 to Cell Press after a 40-year relationship
with the University of Chicago Press (UCP). We certainly
learned a lot about our journal through nine publishers’
proposals, and we remain grateful for the many new ideas
that we received about how to make AJHG even better!
With the able assistance of publishing consultant Cara
Kaufman, and a task force of Society members, we met
in Phoenix prior to the spring 2007 board of directors’
meeting and made the business decision to leave UCP.
UCP staff, especially Everett Connor and Alec Dinwoodie,
had become cherished friends of ASHG over the many
years, and the parting was not without remorse for this
loss. Nonetheless, it was a decision that I and the
members of the task force believed important to move
The Journal forward to better reach the global community
and to enhance its position ﬁnancially to support many
worthy activities of The Society. The transition to Cell
Press went smoothly, with much gratitude due to Robin
Williamson and to the superlative efforts of individuals
at Cell Press, including especially Keith Wollman, and
with appreciation also to Jim Krosschell and Emilie Mar-
cus. The change in publisher meant a change in our
editorial processing system from the home-grown system
at UCP, known as WPR (‘‘whipper’’), to Aries Editorial
Manager. We had a few hiccups once the switch was ﬂip-
ped, but this was another change for which the time had
really come, and the new editorial processing capabilities
were much welcomed. Further developments in manu-326 The American Journal of Human Genetics 85, 321–327, Septemscript processing took place with this year’s migration
to the Elsevier Editorial System, and the future will be
one of continuous evaluation and improvements to the
process. From my perspective, AJHG has beneﬁtted in
a number of ways from being a Cell Press journal, sup-
ported by the larger infrastructure of Elsevier. A new
and enhanced web site was launched and various
resources were provided, such as open access to a monthly
featured AJHG article as well as an article selected from
the Cell Press family of journals. Papers are published
ahead of the print version on a weekly basis, and AJHG
papers continue to be open access at six months, an atyp-
ical arrangement for a commercial publisher but an ASHG
core value that was critical in the publisher evaluations.
Podcasts by Drs. Williamson and Bungartz now frequent
the web site, providing another venue to get the word
out about advances in human genetics. As a side note,
in a separate effort, all of the back archives of AJHG
became available through special efforts of staff at the
National Library of Medicine. So, you may now proceed
directly after reading these recollections to PubMed
Central to download President Muller’s inaugural paper
in AJHG!
But.what has been going on scientiﬁcally in human
genetics during this time? AJHG continues to be a highly -
regarded, if arguably not the most highly coveted, publica-
tion for papers concerning statistical genetics methods,
with its most frequently cited publication, already
mentioned above, being a paper by Richard Spielman and
colleagues, about a transmission test for linkage disequilib-
rium, fondly known as TDT.6 Recognizing this paper is
certainly bittersweet at this time because of the recent
untimely death of Rich, whose future contributions to
AJHG will be sorely missed! During my editorship, the top
cited paper is another methods paper, by Shaun Purcell
and coauthors,11 concerning a free, open-source, whole-
genome association analysis toolset, designed to perform
a range of basic, large-scale analyses in a computationally
efﬁcient manner, known as PLINK. Gene discovery papers
still ﬁgure prominently in AJHG, although citation rates
for some of these rarer disorders are often not high, which
has an impact on our impact factor. Lastly, it goes without
saying that this has really been the time of genome-wide
association studies. Although perhaps not the top genetics
journal for publishing themost cutting edge GWAS papers,
AJHG receives a number of these manuscripts and has been
rigorous in its review of them, being at the table with the
community of leading investigators trying to sort out the
criteria necessary for signiﬁcance, replication, and valida-
tion of the ﬁndings.
So, happy 60th birthday, AJHG! My wish is that you will
go forward in the next 60 years to be so cherished as you
have been by the six editors who have written about you
here. And, for the AJHG editors to come, may you enjoy
your editorships as much as we have and welcome the
opportunity to serve a society of human geneticists that
we have all so loved.ber 11, 2009
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